Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies

内科学 医学 前瞻性队列研究 队列 肿瘤科 计算机科学
作者
Teerha Piratvisuth,Jinlin Hou,Tawesak Tanwandee,Thomas Berg,Arndt Vogel,Jörg Trojan,Enrico N. De Toni,Masatoshi Kudo,Anja Eiblmaier,Hanns‐Georg Klein,Johannes Kolja Hegel,Kairat Madin,Konstantin Kroeniger,Ashish Sharma,Henry Lik‐Yuen Chan
出处
期刊:Hepatology communications [Lippincott Williams & Wilkins]
卷期号:7 (11) 被引量:18
标识
DOI:10.1097/hc9.0000000000000317
摘要

Background: Alpha-fetoprotein (AFP) and des-gamma carboxyprothrombin (DCP), also known as protein induced by vitamin K absence-II (PIVKA-II [DCP]) are biomarkers for HCC with limited diagnostic value when used in isolation. The novel GAAD algorithm is an in vitro diagnostic combining PIVKA-II (DCP) and AFP measurements, age, and gender (biological sex) to generate a semi-quantitative result. We conducted prospective studies to develop, implement, and clinically validate the GAAD algorithm for differentiating HCC (early and all-stage) and benign chronic liver disease (CLD), across disease stages and etiologies. Methods: Patients aged ≥18 years with HCC or CLD were prospectively enrolled internationally into algorithm development [n = 1084; 309 HCC cases (40.7% early-stage) and 736 controls] and clinical validation studies [n = 877; 366 HCC cases (47.6% early-stage) and 303 controls]. Serum samples were analyzed on a cobas ® e 601 analyzer. Performance was assessed using receiver operating characteristic curve analyses to calculate AUC. Results: For algorithm development, AUC for differentiation between early-stage HCC and CLD was 90.7%, 84.4%, and 77.2% for GAAD, AFP, and PIVKA-II, respectively. The sensitivity of GAAD for the detection of early-stage HCC was 71.8% with 90.0% specificity. Similar results were shown in the clinical validation study; AUC for differentiation between early-stage HCC and CLD was 91.4% with 70.1% sensitivity and 93.7% specificity. GAAD also showed strong specificity, with a lower rate of false positives regardless of disease stage, etiology, or region. Conclusions: The GAAD algorithm significantly improves early-stage HCC detection for patients with CLD undergoing HCC surveillance. Further phase III and IV studies are warranted to assess the utility of incorporating the algorithm into clinical practice.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
pyj完成签到,获得积分10
刚刚
Mahc完成签到,获得积分10
2秒前
2秒前
我是老大的应助被端庄威采纳,获得10
2秒前
Orange的应助被热爱科研的小孩采纳,获得10
3秒前
FashionBoy的应助被阿盛采纳,获得10
3秒前
4秒前
nini完成签到,获得积分10
4秒前
bkagyin的应助被简单的飞凤采纳,获得10
5秒前
AnnChen发布了新的文献求助10
5秒前
华仔的应助被LL采纳,获得10
6秒前
zfr完成签到 ,获得积分10
6秒前
Ma发布了新的文献求助10
6秒前
yy发布了新的文献求助30
6秒前
完美世界的应助被exile采纳,获得10
7秒前
嘻嘻哈哈发布了新的文献求助210
7秒前
zzk发布了新的文献求助10
7秒前
11发布了新的文献求助10
8秒前
彭于晏的应助被saiki采纳,获得10
8秒前
9秒前
9秒前
踏实的曲奇完成签到,获得积分10
9秒前
10秒前
mtt完成签到,获得积分10
10秒前
abandon发布了新的文献求助10
11秒前
多啦a萌完成签到,获得积分20
12秒前
12秒前
wjsbhsn完成签到,获得积分20
13秒前
lisa完成签到,获得积分10
13秒前
玫瑰发布了新的文献求助20
13秒前
多啦a萌发布了新的文献求助10
14秒前
这里有妖气完成签到,获得积分10
14秒前
风飒飒完成签到 ,获得积分10
15秒前
张婷完成签到,获得积分10
15秒前
乎乎发布了新的文献求助30
15秒前
草莓软糖发布了新的文献求助10
16秒前
xiaoguoxiaoguo完成签到,获得积分10
16秒前
abandon完成签到,获得积分10
16秒前
16秒前
华仔的应助被Happyocean采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148